EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $558,530 | -30.6% | 28,731 | +1.3% | 0.00% | 0.0% |
| Q1 2023 | $804,913 | +4.9% | 28,372 | +8.0% | 0.00% | 0.0% |
| Q4 2022 | $767,550 | +3.2% | 26,259 | -6.7% | 0.00% | 0.0% |
| Q3 2022 | $744,000 | -0.1% | 28,150 | +68.0% | 0.00% | 0.0% |
| Q2 2022 | $745,000 | -14.6% | 16,757 | -4.9% | 0.00% | 0.0% |
| Q1 2022 | $872,000 | -8.0% | 17,613 | -5.4% | 0.00% | 0.0% |
| Q4 2021 | $948,000 | +2.6% | 18,625 | +12.4% | 0.00% | 0.0% |
| Q3 2021 | $924,000 | +203.9% | 16,568 | +119.4% | 0.00% | 0.0% |
| Q4 2018 | $304,000 | -76.3% | 7,551 | -64.8% | 0.00% | -66.7% |
| Q3 2017 | $1,281,000 | -35.6% | 21,472 | -14.8% | 0.00% | -40.0% |
| Q2 2017 | $1,989,000 | – | 25,213 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |